Table 1: Clinical
characteristics of the 3 patients to whom chloral hydrate oral solution was
administered via IV route.
|
Age |
IV chloral hydrate dose |
Cardiotoxicity |
CNS depression |
Respiratory depression |
Skin lesion |
|
|
|
|
|
|
|
Case 1 (Sing et al.) |
3 years |
39 mg/kg |
no |
yes/short-time lethargy |
no |
yes |
|
|
|
|
|
|
|
Case 2 (Sing et al.) |
15 months |
88 mg/kg |
no |
yes/short-time lethargy |
yes |
yes |
|
|
|
|
|
|
|
Case 3 (Cokyaman
et al.) |
1 years |
50 mg/kg |
no |
no |
no |
yes |